General information

Announcements(0)

Greetings from the Chair

Overview

Web abstract

Best Student Presentation Award

Selected programs of presentations in English

Registration

Registration (Non-presenters under 4th year underg

Information for Participants

Information for Presenters and Chairs

Banquet

Luncheon Seminar & Career Design Seminar

General information 2

Abstract Submission (Oral/Poster Presentation) for

Abstract Submission (Oral/Poster Presentation)

Timetable

Fri. Mar 29, 2024

Sat. Mar 30, 2024

Sun. Mar 31, 2024

Program

Sessions

Search presentations

20230323085903895_en.png

app_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br><br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Update on the development of adverse outcome pathway (AOP) for immunotoxicity and related OECD test guideline

Various molecular networks are activated in diseases. In this symposium, we will focus on dynamism in the activation state of molecular networks in diseases caused by changes in molecular expression levels, activities, and interactions. Recent advances in development of Adverse Outcome Pathways (AOP) and New Approach Methodologies (NAMs) in the OECD etc., will be explained. Introducing the subsequent development of the symposium S52 "Molecular Pathway-based Prediction of Adverse Events in OECD <i>etc</i>." at the 139th Annual Meeting of the Pharmaceutical Society of Japan held in 2019, the status of international joint research on AOP development brought about by molecular network research, its application in various fields will be summarized. In addition, we will introduce the perspectives and status of immunotoxicity-related initiatives in AOP development and OECD testing guidelines and discuss database analysis and machine learning analysis of AOP elements such as Molecular Initiating Event (MIE) and Key Event (KE) related to adverse drug reactions and drug activity prediction for drug discovery. We will discuss NAMs, which have been expanding further in recent years, including AOP networks and quantitative structure activity relationships (QSAR) as main topics.

International Trends in Safety Evaluation with Molecular Networks and New Approach Methodologies (NAMs) in Diseases

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Presentation Information

[JS07-2]Update on the development of adverse outcome pathway (AOP) for immunotoxicity and related OECD test guideline

Password required to view